Intravesical sequential gemcitabine/docetaxel for non-muscle invasive bladder cancer: tips and tricks for better efficacy and tolerability
J Chemother
.
2024 Dec;36(8):694-697.
doi: 10.1080/1120009X.2024.2325765.
Epub 2024 Mar 4.
Authors
Mohamad Abou Chakra
1
,
Mohamad Moussa
2
,
Michael A O'Donnell
1
Affiliations
1
Department of Urology, University of IA, Iowa City, IA, USA.
2
Department of Urology, Lebanese University, Al Zahraa Hospital, Beirut, Lebanon.
PMID:
38439550
DOI:
10.1080/1120009X.2024.2325765
No abstract available
Grants and funding
P30 CA086862/CA/NCI NIH HHS/United States